Co-founder and KOL Christian Dani among World Top 2% Scientists

Co-founder and KOL Christian Dani among World Top 2% Scientists

We are proud and happy for our collaborator and co-founder Dr Christian Dani from Institut de Biologie VaIrose and Université Côte d’Azur who was included in the latest World Ranking Top 2% Scientists list recently released by Stanford University.

This ranking is considered the most prestigious worldwide, with 22 scientific fields and 176 subfields taken into account, and reflects the significant influence and research excellence of scientists committed to furthering their knowledge for the benefit of the world.

Christian Dani also ranked #5th among Université Côte d’Azur scientists in the World Scientist and University Rankings 2023 by AD Scientific Index.

Some great acknowledgements for the work and expertise on adipose tissue biology and stem cells that lead to the development of our innovative ExAdEx technology.

—–

Full lists are available at https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/4?fbclid=IwAR0u4xhKMuKGIsi_prZLxOIOaMPzV-LNCmoIlDYua90eybIVIyE6Sl70vyc and https://www.adscientificindex.com/scientist/christian-dani/4606102

Facebook
Twitter
LinkedIn

Latest News

Poster session at IFSCC 2024 with Exsymol

Our Collaboration with Exsymol Monaco at the 34th Congress IFSCC Brazil 2024 We are excited to announce that our scientific research work performed in collaboration

KOL on adipose tissue biology.

Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice). 

Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program). 

Co-inventor of 5 patents

Expert in clinical applications of adipose tissue.

Plastic Reconstructive and Aesthetic Surgeon in Nice.

Member of the Medical Council of Alpes Maritimes region.

Expert for the French National Regulatory Agency ANSM for medical devices.

Certified by French Health Autority HAS (2020-2024).

PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.

Expert in cell therapy and immunology. 

Senior Lecturer (Maitre de conférences).

Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).

Director of « Micoralis » research team at Université Côte d’Azur (Nice).

Founder and CEO of the biotech company Biointerférence (2003-2006).

Co-inventor of 5 patents.

Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.

With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov. 

In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille). 

He is co-inventor of the 2 company’s patent families. 

Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue. 

Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.

With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years. 

He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.

Main areas of expertise: Biotech Startup Business Development; Project management